Lawsuit Overview
April 15, 2022 - An investor in shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Aurinia Pharmaceuticals Inc. in connection with certain allegedly false and misleading statements made between May 7, 2021 and February 25, 2022,. Canada based Aurinia...
You must register (for free) or login to view the entire case.